Open AccessReal-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes
Author(s) -
Masahiko Shimura,
Makoto Fukumatsu,
Jun Tsujimura,
Kazufumi Hirano,
Toshiyuki Sunaya
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s344194
Subject(s) - medicine , aflibercept , central retinal vein occlusion , macular edema , ranibizumab , visual acuity , ophthalmology , adverse effect , surgery , bevacizumab , chemotherapy
To report on the safety and effectiveness of intravitreal aflibercept (IVT-AFL) for macular edema secondary to central retinal vein occlusion (CRVO) in clinical practice in Japan.